Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Chemically programmed antibodies targeting multiple alpha(v) integrins and their effects on tumor-related functions in vitro

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Goswami, R. K.
  • Bajjuri, K. M.
  • Forsyth, J. S.
  • Das, S.
  • Hassenpflug, W.
  • Huang, Z. Z.
  • Lerner, Richard
  • Felding, Brunhilde
  • Sinhe, S. C.

publication date

  • August 2011

journal

  • Bioconjugate Chemistry  Journal

abstract

  • Integrins αvβ3 and αvβ6 are highly expressed on tumor cells and/or by the tumor vasculature of many human cancers, and represent promising targets for anticancer therapy. Novel chemically programmed antibodies (cpAbs) targeting these integrins were prepared using the catalytic aldolase Antibody (Ab) programming strategy. The effects of the cpAbs on cellular functions related to tumor progression were examined in vitro using tumor cell lines and their cognate integrin ligands, fibronectin and osteopontin. The inhibitory functions of the conjugates and their specificity were examined based on interference with cell-cell and cell-ligand interactions related to tumor progression. Cell binding analyses of the anti-integrin cpAbs revealed high affinity for tumor cells that overexpressed αvβ3 and αvβ6 integrins, and weak interactions with αvβ1 and αvβ8 integrins, in vitro. Functional analyses demonstrated that the cpAbs strongly inhibited cell-cell interactions through osteopontin binding, and they had little or no immediate effects on cell viability and proliferation. On the basis of these characteristics, the cpAbs are likely to have a broad range of activities in vivo, as they can target and antagonize one or multiple αv integrins expressed on tumors and tumor vasculatures. Presumably, these conjugates may inhibit the establishment of metastastatic tumors in distant organs through interfering with cell adhesion more effectively than antibodies or compounds targeting one integrin only. These anti-integrin cpAbs may also provide useful reagents to study combined effect of multiple αv integrins on cellular functions in vitro, on pathologies, including tumor angiogenesis, fibrosis, and epithelial cancers, in vivo.

subject areas

  • Antibodies
  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Cell Communication
  • Cell Line, Tumor
  • Fructose-Bisphosphate Aldolase
  • Humans
  • Immunoconjugates
  • Integrin alphaV
  • Integrin alphaVbeta3
  • Integrins
  • Neoplasms
scroll to property group menus

Identity

PubMed Central ID

  • PMC3277862

International Standard Serial Number (ISSN)

  • 1043-1802

Digital Object Identifier (DOI)

  • 10.1021/bc2000879

PubMed ID

  • 21774545
scroll to property group menus

Additional Document Info

start page

  • 1535

end page

  • 1544

volume

  • 22

issue

  • 8

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support